17-alpha-hydroxyprogesterone has been researched along with Diabetes, Gestational in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antsaklis, A; Bellos, I; Daskalakis, G; Hatziagelaki, E; Loutradis, D; Pergialiotis, V | 1 |
| Cleary-Goldman, J; Istwan, NB; Rebarber, A; Rhea, DJ; Russo-Stieglitz, K; Saltzman, DH; Stanziano, GJ | 1 |
1 review(s) available for 17-alpha-hydroxyprogesterone and Diabetes, Gestational
| Article | Year |
|---|---|
Progestogens for the prevention of preterm birth and risk of developing gestational diabetes mellitus: a meta-analysis.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Intravaginal; Diabetes, Gestational; Female; Humans; Pregnancy; Premature Birth; Progesterone; Progestins | 2019 |
1 other study(ies) available for 17-alpha-hydroxyprogesterone and Diabetes, Gestational
| Article | Year |
|---|---|
Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Caproates; Diabetes, Gestational; Female; Humans; Incidence; Injections, Intramuscular; Pregnancy; Premature Birth; Recurrence; Tocolytic Agents | 2007 |